(Q39175682)
Statements
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo (English)
Simona Piaggi
Alessandro Antonelli
Guido Bocci
Silvia Martina Ferrari
Alda Corrado
Anna Fioravanti
Paola Orlandi
Alessandro Corti
Gabriele Materazzi
David Galleri